Is CHLL or HELD more profitable?

Hellenic Dynamics' return on equity of -364.21% beat Chill Brands Group's return on equity. Company Net Margins Return on Equity Return on Assets Chill Brands Group N/A -2,802.21% -44.64% Hellenic Dynamics N/A -364.21% N/A

Do analysts prefer CHLL or HLN?

Haleon has a consensus price target of GBX 395.33, indicating a potential upside of 13.50%. Given Haleon's stronger consensus rating and higher probable upside, analysts clearly believe Haleon is more favorable than Chill Brands Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chill Brands Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Haleon 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Do analysts recommend HIK or CHLL?

Hikma Pharmaceuticals currently has a consensus price target of GBX 1,687, indicating a potential upside of 10.26%. Given Hikma Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe Hikma Pharmaceuticals is more favorable than Chill Brands Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hikma Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Chill Brands Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Chill Brands Group (CHLL) Competitors

GBX 2.50 -0.15 (-5.66%)

As of 05:51 AM Eastern

Compare

CHLL vs. N4P, HELD, HLN, HIK, and INDV

Should you buy Chill Brands Group stock or one of its competitors? MarketBeat compares Chill Brands Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Chill Brands Group include N4 Pharma (N4P), Hellenic Dynamics (HELD), Haleon (HLN), Hikma Pharmaceuticals (HIK), and Indivior (INDV). These companies are all part of the "drug manufacturers - specialty & generic" industry.

How does Chill Brands Group compare to N4 Pharma?

Chill Brands Group (LON:CHLL) and N4 Pharma (LON:N4P) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk.

Chill Brands Group has a net margin of 0.00% compared to N4 Pharma's net margin of -15,603.59%. N4 Pharma's return on equity of -91.34% beat Chill Brands Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chill Brands Group	N/A	-2,802.21%	-44.64%
N4 Pharma	-15,603.59%	-91.34%	-56.00%

In the previous week, N4 Pharma had 1 more articles in the media than Chill Brands Group. MarketBeat recorded 1 mentions for N4 Pharma and 0 mentions for Chill Brands Group. Chill Brands Group's average media sentiment score of 0.00 equaled N4 Pharma'saverage media sentiment score.

Company	Overall Sentiment
Chill Brands Group	Neutral
N4 Pharma	Neutral

1.5% of Chill Brands Group shares are owned by institutional investors. Comparatively, 0.2% of N4 Pharma shares are owned by institutional investors. 10.3% of Chill Brands Group shares are owned by company insiders. Comparatively, 22.0% of N4 Pharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

N4 Pharma has lower revenue, but higher earnings than Chill Brands Group. N4 Pharma is trading at a lower price-to-earnings ratio than Chill Brands Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chill Brands Group	£305.70K	4.28	-£3.64M	-£6.50	N/A
N4 Pharma	£7.07K	800.95	-£1.63M	-£0.24	N/A

Chill Brands Group has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market. Comparatively, N4 Pharma has a beta of -0.37, indicating that its stock price is 137% less volatile than the broader market.

Summary

Chill Brands Group and N4 Pharma tied by winning 6 of the 12 factors compared between the two stocks.

How does Chill Brands Group compare to Hellenic Dynamics?

Chill Brands Group (LON:CHLL) and Hellenic Dynamics (LON:HELD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

In the previous week, Chill Brands Group's average media sentiment score of 0.00 equaled Hellenic Dynamics'average media sentiment score.

Company	Overall Sentiment
Chill Brands Group	Neutral
Hellenic Dynamics	Neutral

Hellenic Dynamics' return on equity of -364.21% beat Chill Brands Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chill Brands Group	N/A	-2,802.21%	-44.64%
Hellenic Dynamics	N/A	-364.21%	N/A

1.5% of Chill Brands Group shares are held by institutional investors. Comparatively, 0.1% of Hellenic Dynamics shares are held by institutional investors. 10.3% of Chill Brands Group shares are held by company insiders. Comparatively, 72.9% of Hellenic Dynamics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Chill Brands Group has higher revenue and earnings than Hellenic Dynamics. Chill Brands Group is trading at a lower price-to-earnings ratio than Hellenic Dynamics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chill Brands Group	£305.70K	4.28	-£3.64M	-£6.50	N/A
Hellenic Dynamics	N/A	N/A	-£5.22M	-£3.55	N/A

Summary

Hellenic Dynamics beats Chill Brands Group on 5 of the 8 factors compared between the two stocks.

How does Chill Brands Group compare to Haleon?

Chill Brands Group (LON:CHLL) and Haleon (LON:HLN) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, media sentiment, analyst recommendations, dividends, earnings, institutional ownership and profitability.

1.5% of Chill Brands Group shares are held by institutional investors. Comparatively, 39.0% of Haleon shares are held by institutional investors. 10.3% of Chill Brands Group shares are held by company insiders. Comparatively, 0.0% of Haleon shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Haleon has a net margin of 12.59% compared to Chill Brands Group's net margin of 0.00%. Haleon's return on equity of 6.43% beat Chill Brands Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chill Brands Group	N/A	-2,802.21%	-44.64%
Haleon	12.59%	6.43%	4.45%

Chill Brands Group has a beta of 0.99, suggesting that its share price is 1% less volatile than the broader market. Comparatively, Haleon has a beta of 0.246, suggesting that its share price is 75% less volatile than the broader market.

Haleon has a consensus price target of GBX 395.33, indicating a potential upside of 13.50%. Given Haleon's stronger consensus rating and higher probable upside, analysts clearly believe Haleon is more favorable than Chill Brands Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chill Brands Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Haleon	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Haleon has higher revenue and earnings than Chill Brands Group. Chill Brands Group is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chill Brands Group	£305.70K	4.28	-£3.64M	-£6.50	N/A
Haleon	£11.03B	2.79	£1.07B	£18.50	18.83

In the previous week, Haleon had 4 more articles in the media than Chill Brands Group. MarketBeat recorded 4 mentions for Haleon and 0 mentions for Chill Brands Group. Haleon's average media sentiment score of 0.21 beat Chill Brands Group's score of 0.00 indicating that Haleon is being referred to more favorably in the news media.

Company	Overall Sentiment
Chill Brands Group	Neutral
Haleon	Neutral

Summary

Haleon beats Chill Brands Group on 13 of the 16 factors compared between the two stocks.

How does Chill Brands Group compare to Hikma Pharmaceuticals?

Hikma Pharmaceuticals (LON:HIK) and Chill Brands Group (LON:CHLL) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

63.6% of Hikma Pharmaceuticals shares are held by institutional investors. Comparatively, 1.5% of Chill Brands Group shares are held by institutional investors. 21.5% of Hikma Pharmaceuticals shares are held by company insiders. Comparatively, 10.3% of Chill Brands Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Hikma Pharmaceuticals has a beta of 0.653, meaning that its stock price is 35% less volatile than the broader market. Comparatively, Chill Brands Group has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market.

Hikma Pharmaceuticals has a net margin of 12.00% compared to Chill Brands Group's net margin of 0.00%. Hikma Pharmaceuticals' return on equity of 15.83% beat Chill Brands Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hikma Pharmaceuticals	12.00%	15.83%	9.40%
Chill Brands Group	N/A	-2,802.21%	-44.64%

Hikma Pharmaceuticals has higher revenue and earnings than Chill Brands Group. Chill Brands Group is trading at a lower price-to-earnings ratio than Hikma Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hikma Pharmaceuticals	£3.35B	0.97	£353.21M	£181.00	8.45
Chill Brands Group	£305.70K	4.28	-£3.64M	-£6.50	N/A

Hikma Pharmaceuticals currently has a consensus price target of GBX 1,687, indicating a potential upside of 10.26%. Given Hikma Pharmaceuticals' stronger consensus rating and higher possible upside, research analysts clearly believe Hikma Pharmaceuticals is more favorable than Chill Brands Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hikma Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Chill Brands Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Hikma Pharmaceuticals had 2 more articles in the media than Chill Brands Group. MarketBeat recorded 2 mentions for Hikma Pharmaceuticals and 0 mentions for Chill Brands Group. Hikma Pharmaceuticals' average media sentiment score of 0.45 beat Chill Brands Group's score of 0.00 indicating that Hikma Pharmaceuticals is being referred to more favorably in the media.

Company	Overall Sentiment
Hikma Pharmaceuticals	Neutral
Chill Brands Group	Neutral

Summary

Hikma Pharmaceuticals beats Chill Brands Group on 14 of the 16 factors compared between the two stocks.

How does Chill Brands Group compare to Indivior?

Indivior (LON:INDV) and Chill Brands Group (LON:CHLL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

Indivior has higher revenue and earnings than Chill Brands Group. Indivior is trading at a lower price-to-earnings ratio than Chill Brands Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Indivior	£1.40B	1.38	-£2.36M	-£1.21	N/A
Chill Brands Group	£305.70K	4.28	-£3.64M	-£6.50	N/A

Indivior has a beta of 0.19, indicating that its stock price is 81% less volatile than the broader market. Comparatively, Chill Brands Group has a beta of 0.99, indicating that its stock price is 1% less volatile than the broader market.

Indivior has a net margin of 14.30% compared to Chill Brands Group's net margin of 0.00%. Indivior's return on equity of -41.70% beat Chill Brands Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Indivior	14.30%	-41.70%	2.37%
Chill Brands Group	N/A	-2,802.21%	-44.64%

In the previous week, Indivior had 2 more articles in the media than Chill Brands Group. MarketBeat recorded 2 mentions for Indivior and 0 mentions for Chill Brands Group. Indivior's average media sentiment score of 0.74 beat Chill Brands Group's score of 0.00 indicating that Indivior is being referred to more favorably in the media.

Company	Overall Sentiment
Indivior	Positive
Chill Brands Group	Neutral

86.0% of Indivior shares are owned by institutional investors. Comparatively, 1.5% of Chill Brands Group shares are owned by institutional investors. 3.4% of Indivior shares are owned by company insiders. Comparatively, 10.3% of Chill Brands Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Indivior beats Chill Brands Group on 9 of the 13 factors compared between the two stocks.

Get Chill Brands Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CHLL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CHLL vs. The Competition

Export

Metric	Chill Brands Group	Drug Manufacturers Industry	Medical Sector	LON Exchange
Market Cap	£1.31M	£2.44B	£6.79B	£2.77B
Dividend Yield	N/A	2.94%	2.68%	6.16%
P/E Ratio	-0.38	4.99	25.68	366.66
Price / Sales	4.28	1,652.29	554.75	85,978.63
Price / Cash	11.50	10.18	46.33	27.87
Price / Book	N/A	10.80	10.70	7.76
Net Income	-£3.64M	£20.27B	£3.57B	£5.89B
7 Day Performance	-2.72%	-0.68%	2.38%	-0.72%
1 Month Performance	-16.67%	-1.55%	1.56%	-1.20%
1 Year Performance	N/A	10.86%	31.69%	65.93%

Chill Brands Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CHLL Chill Brands Group	N/A	GBX 2.50 -5.7%	N/A	N/A	£1.31M	£305.70K	N/A	7	Gap Up
N4P N4 Pharma	N/A	GBX 0.68 flat	N/A	+70.0%	£5.66M	£7.07K	N/A	5
HELD Hellenic Dynamics	N/A	GBX 0.01 -98.9%	N/A	N/A	£14K	N/A	N/A	N/A	Gap Down
HLN Haleon	2.6209 of 5 stars	GBX 336.90 +0.0%	GBX 398.67 +18.3%	-8.7%	£29.81B	£11.03B	18.21	25,408	News Coverage Analyst Forecast High Trading Volume
HIK Hikma Pharmaceuticals	3.1151 of 5 stars	GBX 1,480 flat	GBX 2,128 +43.8%	-24.9%	£3.15B	£3.35B	8.18	9,100

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:CHLL) was last updated on 6/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Chill Brands Group (CHLL) Competitors

CHLL vs. N4P, HELD, HLN, HIK, and INDV

How does Chill Brands Group compare to N4 Pharma?

Summary

How does Chill Brands Group compare to Hellenic Dynamics?

Summary

How does Chill Brands Group compare to Haleon?

Summary

How does Chill Brands Group compare to Hikma Pharmaceuticals?

Summary

How does Chill Brands Group compare to Indivior?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CHLL vs. The Competition

Chill Brands Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Chill Brands Group (CHLL) Competitors

CHLL vs. N4P, HELD, HLN, HIK, and INDV

How does Chill Brands Group compare to N4 Pharma?

Is CHLL or N4P more profitable?

Does the media refer more to CHLL or N4P?

Do insiders & institutionals have more ownership in CHLL or N4P?

Which has higher earnings & valuation, CHLL or N4P?

Which has more volatility and risk, CHLL or N4P?

Summary

How does Chill Brands Group compare to Hellenic Dynamics?

Does the media prefer CHLL or HELD?

Is CHLL or HELD more profitable?

Do institutionals and insiders hold more shares of CHLL or HELD?

Which has better earnings & valuation, CHLL or HELD?

Summary

How does Chill Brands Group compare to Haleon?

Do insiders & institutionals hold more shares of CHLL or HLN?

Is CHLL or HLN more profitable?

Which has more volatility and risk, CHLL or HLN?

Do analysts prefer CHLL or HLN?

Which has stronger valuation & earnings, CHLL or HLN?

Does the media refer more to CHLL or HLN?

Summary

How does Chill Brands Group compare to Hikma Pharmaceuticals?

Do insiders & institutionals have more ownership in HIK or CHLL?

Which has more volatility & risk, HIK or CHLL?

Is HIK or CHLL more profitable?

Which has preferable valuation & earnings, HIK or CHLL?

Do analysts recommend HIK or CHLL?

Does the media favor HIK or CHLL?

Summary

How does Chill Brands Group compare to Indivior?

Which has better valuation and earnings, INDV or CHLL?

Which has more volatility & risk, INDV or CHLL?

Is INDV or CHLL more profitable?

Does the media refer more to INDV or CHLL?

Do institutionals & insiders believe in INDV or CHLL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CHLL vs. The Competition

Chill Brands Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools